THIS IS a jet-propelled age in which epoch-making strides bring about an ever changing scene. Even before the printer's ink dries, extolling the virtues of some newly discovered antibiotic, another in vitro experiment is in line to offer even greater promise of conquering diseases which up to then have been medical enigmas. The advent of each successive chemotherapeutic or antibiotic agent gives rise to mixed emotional reactions among all physicians, no less the otologist. Some physicians treat the new agent like that of an intruder in their midst, a threat to the very existence of a rather well established modality in a specialty, and they resist the very application of the proved agent. The other extreme is represented by a group of physicians who give up the thorough, though time-consuming, history-taking and careful study of the patient and indiscriminately and fearlessly dose the patient.
Such promiscuousness in therapy is frequently
LEDERER FL. THE MAGINOT LINE OF OTOLOGY: Dependence on Antibiotics in Suppurative Middle Ear Disease; Facts and Fancies. Arch Otolaryngol. 1950;52(4):533–537. doi:10.1001/archotol.1950.00700030557002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: